Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia

A phase 2 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 113 participants.

Also called NCT01972178

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 113 participants (enrolled count) (from the registry)
Sponsor
Pronova BioPharma (from the registry)
Registry
  • NCT NCT01972178
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States (from the registry)
Registry status
  • Terminated (from the registry)

Technical summary

Registry record NCT01972178. Randomized; double masking; primary purpose treatment. Start 2013-11 (registry gives no type); primary completion 2014-07 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
Condition
Dyslipidemia
Intervention (Drug)
PRC-4016
Intervention (Drug)
Placebo
Intervention (Drug)
Statins
Lead sponsor
Pronova BioPharma (class: industry)

Record details

Record id
cardio:ct-nct01972178
Content hash
540fae9737c6db254ae2e2b75e4b3d10ff4bcbb12294cf663f2fc8847f686616